Somatostatin receptors

Digestion

Volumn 62, Issue SUPPL. 1, 2000, Pages 27-32

  Benali, Naoual ^a   Ferjoux, Geraldine ^a   Puente, Elena ^a   Buscail, Louis ^a   Susini, Christiane ^a  

^a CHU RANGUEIL   (France)

Author keywords

Biological function; Expression; Receptor; Signal transduction; Somatostatin

Indexed keywords

RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR;

CELL MOTILITY; CELL PROLIFERATION; CELL SECRETION; CONFERENCE PAPER; GROWTH HORMONE RELEASE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; SOMATOSTATIN RELEASE;

EID: 0033843209     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051852     Document Type: Conference Paper

References (44)

1. Epelbaum J, Dournaud P, Fodor M, Viollet C: The neurobiology of somatostatin. Crit Rev Neurobiol 1994;8:25-44.
2. Rohrer SP, Birzin ET, Mosley RT, Berk SC, Hutchins SM, Shen DM, Xiong Y, Hayes EC, Parmar RM, Foor F, Mitra SW, Degrade SJ, Shu M, Klopp JM, Cai SJ, Blake A, Chan WWS, Pasternak A, Yang L, Patchett AA, Smith RG, Chapman KT, Schaeffer JM: Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 1998;282:737-740.
3. Schally AV: Oncological applications of somatostatin analogues. Cancer Res 1988;48:6977-6985. (Published erratum appears in Cancer Res 1989;49:1618).
4. Reubi JC, Schaer JC, Markwalder R, Waser B, Horisberger U, Laissue J: Distribution of somatostatin receptors in normal and neoplastic human tissues: Recent advances and potential relevance. Yale J Biol Med 1997;70:471-479.
5. Meyerhof W: The elucidation of somatostatin receptor functions: A current view. Rev Physiol Biochem Pharmacol 1998;133:55-108.
6. Bruns C, Weckbecker G, Raulf F, Lubbert H, Hover D: Characterization of somatostatin receptor subtypes. Ciba Found Symp 1995;190: 89-101; discussion 101-110.
7. 2+ currents in rat insulinoma 1046-38 cells. FEBS Lett 1998;425:137-140.
8. Buscail L, Delesque N, Esteve JP, Saint-Laurent N, Prats H, Clerc P, Robberecht P, Bell GI, Liehow C, Schally AV, et al: Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: Mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci USA 1994;91:2315-2319.
9. Reardon DB, Dent P, Wood SL, Kong T, Sturgill TW: Activation in vitro of somatostatin receptor subtypes 2, 3, or 4 stimulates protein tyrosine phosphatase activity in membranes from transfected Ras-transformed NIH 3T3 cells: Coexpression with catalytically inactive SHP-2 blocks responsiveness. Mol Endocrinol 1997;11:1062-1069.
10. Murthy KS, Coy DH, Makhlouf GM: Somatostatin receptor-mediated signaling in smooth muscle. Activation of phospholipase C-beta3 by Gbetagamma and inhibition of adenylyl cyclase by Galphail and Galphao. J Biol Chem 1996;271:23458-23463.
11. Buscail L, Esteve JP, Saint-Laurent N, Bertrand V, Reisine T, AM OC, Bell GI, Schally AV, Vaysse N, Susini C: Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc Natl Acad Sci USA 1995;92:1580-1584.
12. Florio T, Yao H, Carey KD, Dillon TJ, Stork PJ: Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1). Mol Endocrinol 1999;13:24-37.
13. Sellers LA, Fcniuk W, Humphrey PP, Lauder H: Activated G protein-coupled receptor induces tyrosine phosphorylation of STAT3 and agonist-selective serine phosphorylation via sustained stimulation of mitogen-activated protein kinase. Resultant effects on cell proliferation. J Biol Chem 1999;274:16423-16430.
14. Cordelier P, Esteve JP, Bousquet C, Delesque N, AM OC, Schally AV, Vaysse N, Susini C, Buscail L: Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5. Proc Natl Acad Sci USA 1997;94:9343-9348.
15. Reubi JC, Schaer JC, Waser B, Mengod G: Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res 1994;54:3455-3459.
16. Dutour A, Kumar U, Panetta R, Ouafik L, Fina F, Sasi R, Patel YC: Expression of somatostatin receptor subtypes in human brain tumors. Int J Cancer 1998;76:620-627.
17. Schulz S, Schulz, S, Schmitt J, Wiborny D, Schmidt H, Olbrieht S, Weise W, Roessner A, Gramsch C, Hollt V: Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies. Clin Cancer Res 1998;4:2047-2052.
18. Janson ET, Stridsberg M, Gobi A, Westlin JE, Oberg K: Determination of somatostatin receptor subtype 2 in carcinoid tumors by immunohistochemical investigation with somatostatin receptor subtype 2 antibodies. Cancer Res 1998;58:2375-2378.
19. Hofland LJ, Liu Q, Van Koetsveld PM, Zuijderwijk J, Van Der Ham F, De Krijger RR, Schonbrunn A, Lamberts SW: Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors. J Clin Endocrinol Metab 1999;84:775-780.
20. Buscail L, Saint-Laurent N, Chastre E, Vaillant JC, Gespach C, Capella G, Kalthoff H, Lluis F, Vaysse N, Susini C: Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. Cancer Res 1996;56: 1823-1827.
21. Patel YC: Molecular pharmacology of somatostatin receptor subtypes. J Endocrinol Invest 1997;20:348-367.
22. Zheng H, Bailey A, Jiang MH, Honda K, Chen HY, Trumbauer ME, Van der Ploeg LH, Schaeffer JM, Leng G, Smith RG: Somatostatin receptor subtype 2 knockout mice are refractory to growth hormone-negative feedback on arcuate neurons. Mol Endocrinol 1997;11: 1709-1717.
23. Kreienkamp HJ, Akgun E, Baumeister H, Meyerhof W, Richter D: Somatostatin receptor subtype 1 modulates basal inhibition of growth hormone release in somatotrophs. FEBS Lett 1999;462:464-466.
24. Moldovan S, Atiya A, Adrian TE, Kleinman RM, Lloyd K, Olthoff K, Imagawa D, Shevlin L, Coy D, Walsh J, et al: Somatostatin inhibits B-cell secretion via a subtype-2 Somatostatin receptor in the isolated perfused human pancreas. J Surg Res 1995;59:85-90.
25. Kumar U, Sasi R, Suresh S, Patel A, Thangaraju M, Metrakos P, Patel SC, Patel YC: Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: A quantitative double-label immunohistochemical analysis. Diabetes 1999;48:77-85.
26. Martinez V, Curi AP, Torkian B, Schaeffer JM, Wilkinson HA, Walsh JH, Tache Y: High basal gastric acid secretion in somatostatin receptor subtype 2 knockout mice. Gastroenterology 1998;114:1125-1132.
27. Glassmeier G, Hopfner M, Riecken EO, Mann B, Buhr H, Neuhaus P, Meyerhof W, Scherubl H: Inhibition of L-type calcium channels by octreotide in isolated human neuroendocrine tumor cells of the gut. Biochem Biophys Res Commun 1998;250:511-515.
28. Gu ZF, Corleto VD, Mantcy SA, Coy DH, Maton PN, Jensi RT: Somatostatin receptor subtype 3 mediates the inhibitory action of somatostatin on gastric smooth muscle cells. Am J Physiol 1995;268:G739-G748.
29. Sharma K, Patel YC, Srikant CB: C-terminal region of human somatostatin receptor 5 is required for induction of Rb and GI cell cycle arrest. Mol Endocrinol 1999;13:82-90.
30. Alderton F, Fan TP, Schindler M, Humphrey PP: Rat somatostatin sst2(a) and sst2(b) receptor isoforms mediate opposite effects on cell proliferation. Br J Pharmacol 1998;125:1630-1633.
31. Bousquet C, Delesque N, Lopez F, Saint-Laurent N, Esteve JP, Bedees K, Buscail L, Vaysse N, Susini C: sst2 somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase Shp-1. J Biol Chem 1998;273:7099-7106.
32. Pages P, Benali N, Saint-Laurent N, Esteve JP, Schally AV, Tkaczuk J, Vaysse N, Susini C, Buscail L: sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kipl). Evidence for the role of Shp-1. J Biol Chem 1999;274:15186-15193.
33. Sharma K, Srikant CB: Induction of wild-type p53, Bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells. Int J Cancer 1998;76: 259-266.
34. Rochaix P, Delesque N, Esteve JP, Saint-Laurent N, Voight JJ, Vaysse N, Susini C, Buscail L: Gene therapy for pancreatic carcinoma: Local and distant antitumor effects after somatostatin receptor sst2 gene transfer. Hum Gene Ther 1999;10:995-1008.
35. Reubi JC, Waser B, Lamberts SW, Mengod G: Somatostatin (SRIH) messenger ribonucleic acid expression in human neuroendocrine and brain tumors using in situ hybridization histochemistry: Comparison with SRIH receptor content. J Clin Endocrinol Metab 1993;76: 642-647.
36. Delesque N, Buscail L, Esteve JP, Saint-Laurent N, Muller C, Weckbecker G, Bruns C, Vayssc N, Susini C: sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells. Cancer Res 1997;57: 956-962.
37. Macaulay VM: Insulin-like growth factors and cancer. Br J Cancer 1992;65:311-320.
38. Serri O, Brazeau P, Kachra Z, Posner B: Octreotide inhibits insulin-like growth factor-I hepatic gene expression in the hypophysectomized rat: Evidence for a direct and indirect mechanism of action. Endocrinology 1992; 130:1816-1821.
39. Reubi JC, Horisberger U, Laissue J: High density of somatostatin receptors in veins surrounding human cancer tissue: Role in tumor-host interaction? Int J Cancer 1994;56:681-688.
40. Albini A, Florio T, Giunciuglio D, Masiello L, Carlone S, Corsaro A, Thcllung S, Cai T, Noonan DM, Schettini G: Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis. FASEB J 1999;13:647-655.
41. van Hagen PM, Krenning EP, Kwekkeboom DJ, Reubi JC, Anker-Lugtenburg PJ, Lowenberg B, Lamberts SW: Somatostatin and the immune and haematopoctic system: A review. Eur J Clin Invest 1994;24:91-99.
42. Hipkin RW, Friedman J, Clark RB, Eppler CM, Schonbrunn A: Agonist-induced desensitization, internalization, and phosphorylation of the sst2A somatostatin receptor. J Biol Chem 1997;272:13869-13876.
43. Hukovic N, Panetta R, Kumar U, Rocheville M, Patel YC: The cytoplasmic tail of the human somatostatin receptor type 5 is crucial for interaction with adenylyl cyclase and in mediating desensitization and internalization. J Biol Chem 1998;273:21416-21422.
44. Froidevaux S, Hintermann E, Torok M, Macke HR, Beglinger C, Eberle AN: Differential regulation of somatostatin receptor type 2 (sst2) expression in AR4-2J tumor cells implanted into mice during octreotide treatment. Cancer Res 1999;59:3652-3657.